With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well?

Return on Equity (ROE) measures a company's profit generation from shareholder investments. Puma Biotechnology's ROE of 18% is respectable, but its high debt level raises risks. ROE is a key indicator of a company's ability to generate profits and shareholder returns.